Alpelisib
Brand name: Piqray
Alpelisib comes in 9 pill versions in our database, in 5 strengths, from 2 manufacturers. Check the imprint to tell them apart.
Alpelisib pill images
50 mg 2 pills
- C7 NVR Alpelisib 50 mg Yellow, round, 7 mm Used for breast cancer and male breast neoplasms
- L7 NVR Alpelisib 50 mg Pink, round, 7 mm Used for breast cancer and male breast neoplasms
125 mg 1 pill
150 mg 2 pills
- UL7 NVR Alpelisib 150 mg Red, oval, 14 mm Used for breast cancer and male breast neoplasms
- UL7 NVR Alpelisib 150 mg Red, oval Used for breast cancer and male breast neoplasms
200 mg 3 pills
- CL7 NVR Alpelisib 200 mg Yellow, oval, 16 mm Used for breast cancer and male breast neoplasms
- YL7 NVR Alpelisib 200 mg Red, oval, 16 mm Used for breast cancer and male breast neoplasms
- YL7 NVR Alpelisib 200 mg Red, oval Used for breast cancer and male breast neoplasms
200 mg / 50 mg 1 pill
What is Alpelisib used for?
Alpelisib is used for breast cancer and male breast neoplasms.
Official uses from the US prescribing label
PIQRAY is indicated in combination with fulvestrant for the treatment of adults with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CA-mutated, advanced or metastatic breast cancer as detected by an FDA-approved test following progression on or after an endocrine-based regimen.
From the FDA-approved label on DailyMed (published Dec 16, 2025).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.